home / stock / bcab / bcab message board
Subject | By | Source | When |
---|---|---|---|
BCAB $2.47 Pfizer filed form 4 back in | DDHOUND | investorshub | 03/30/2023 5:31:49 PM |
BioAtla Announces $65 Million Underwritten Offering of its | crudeoil24 | investorshub | 11/04/2022 1:12:23 PM |
BioAtla Initiated at Market Outperform by JMP Securities | crudeoil24 | investorshub | 11/04/2022 1:02:44 PM |
BioAtla Reports Q3 2022 Cash Balance Of $178.1M | crudeoil24 | investorshub | 11/04/2022 1:01:55 PM |
In a report released today, Arthur He CFA | crudeoil24 | investorshub | 11/04/2022 1:00:53 PM |
BioAtla, Inc. is a clinical-stage biopharmaceutical company focused | crudeoil24 | investorshub | 11/04/2022 12:40:29 PM |
znewcar1: BCAB 48% v6,9M c11.87 f37,5M H12.15 ML3.16 | znewcar1 | investorshangout | 08/16/2022 8:18:23 PM |
znewcar1: BCAB 83% v19M c6.61 f37,4M H7.37 ML3.16 BO3.89 pushed to 6 got S@5 then higher | znewcar1 | investorshangout | 08/10/2022 8:08:39 PM |
News, Short Squeeze, Breakout and More Instantly...
BioAtla Inc. Company Name:
BCAB Stock Symbol:
NASDAQ Market:
SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (NASDAQ:BCAB), a global clinical-stage biotechnology company focused on the developm...
SAN DIEGO, April 24, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, today announced a poster presentation at the upcomin...
Iochpe-Maxion S.A. ADR (IOCJY) is expected to report for quarter end 2023-12-31 The Alkaline Water Company Inc. (WTER) is expected to report for Q3 2024 Clover Leaf Capital Corp. (CLOE) is expected to report for Q4 2023 Silvergate Capital Corporation Class A (SICP) is expected to repo...